Cefepime Side Effects
Brand Names: Maxipime
Please note - some side effects for Cefepime may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
Side Effects of Cefepime - for the Consumer
Cefepime
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Cefepime:
Seek medical attention right away if any of these SEVERE side effects occur when using Cefepime:Diarrhea; headache; nausea; vomiting.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody stools; confusion; decreased urination; fever; hallucinations; hoarseness; loss of consciousness; mental/mood change; muscle twitching; pain, redness, or swelling at the injection site; red, swollen, or blistered skin; seizures; severe diarrhea; severe nausea or vomiting; stomach pain/cramps; unusual bruising or bleeding; unusual tiredness; vaginal irritation or discharge; white patches in the mouth; yellowing of the skin or eyes.
Cefepime Side Effects - for the Professional
Cefepime
- The most common adverse reactions (incidence ≥ 1 %) were local reactions (including phlebitis), pain and/or inflammation, and rash. (6)
To report SUSPECTED ADVERSE REACTIONS, contact Baxter at 1-866-888-2472 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Side Effects by Body System
General
Cefepime is generally well tolerated. It has been reported that 1.5% of patients discontinued medication due to adverse events.
Hypersensitivity
Hypersensitivity reactions have included anaphylaxis, including anaphylactic shock, rash, and pruritus. Acute hypersensitivity myocarditis has been reported. Cephalosporin class antibiotics have been associated with allergic reactions, Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis.
The incidence of discontinuation because of rash has been reported to increase with higher recommended doses.
Anaphylactic reactions are rare, but may occur, especially in patients with a history of penicillin allergy.
Local
Local side effects associated with the administration of cefepime have included phlebitis (1.3%) after intravenous injection, and pain or inflammation (0.6%) after intramuscular injection. Infusion site reaction has also been reported.
Gastrointestinal
Gastrointestinal side effects have included colitis (including pseudomembranous colitis), diarrhea, nausea, vomiting, and oral moniliasis 0.1% to 1% of patients. Abdominal pain, anorexia, stomatitis, and Clostridium difficile-associated diarrhea have also been reported.
If diarrhea occurs which is unresponsive to discontinuation of cefepime and/or standard therapy, pseudomembranous colitis should be considered.
Higher doses (2 grams every 8 hours) have been associated with a greater incidence of side effects, including diarrhea (3%), nausea (2%), and vomiting (1%).
Nervous system
Neurological side effects have included headaches (0.1 to 1%). Encephalopathy (confusion, hallucinations, stupor, and coma), myoclonus, seizures, and nonconvulsive status epilepticus have been reported, mostly in patients receiving higher than recommended dosages. Somnolence has also been reported.
Case reports of seizure activity, with and without convulsions, associated with cefepime have been published in the medical literature. In the vast majority of cases, the patient involved had a clinically significant degree of renal dysfunction. In each case, seizure activity abated upon the discontinuation of cefepime.
Higher doses (2 grams every 8 hours) have been associated with a greater incidence of headache (1%).
A 66-year-old female developed acute renal failure, altered level of consciousness (Glasgow Coma Scale 6), and nonconvulsive status epilepticus after 10 days of cefepime 2 g every 8 hours. Symptoms resolved and she completely recovered 72 hours after discontinuation of cefepime.
Hematologic
Hematological side effects have included transient leukopenia, neutropenia, agranulocytosis, and thrombocytopenia. Cephalosporins as a class have been associated with aplastic anemia, hemolytic anemia, prolonged prothrombin time, hemorrhage, and pancytopenia. Epistaxis has also been reported.
Hepatic
Hepatic side effects associated with cephalosporins as a class have included hepatic dysfunction including cholestasis.
Renal
Renal side effects have included renal failure, mostly in patients with renal impairment who received higher than recommended doses of cefepime. Cephalosporins as a class have been associated with renal dysfunction and toxic nephropathy.
Dermatologic
Higher doses (2 grams every 8 hours) have been associated with a higher incidence of rash (4%) and pruritus (1%).
Dermatologic side effects have included rash (1.1%), urticaria (0.1% to 1%), and pruritus (0.1% to 1%).
Genitourinary
Genitourinary side effects have included vaginitis (0.1% to 1%).
Other
Fever has been reported in 0.1% to 1% of patients.
Higher doses (2 grams every 8 hours) have been associated with a greater incidence of fever (1%).
Metabolic
Metabolic side effects have included hypokalemia, hypomagnesemia, and hypophosphatemia.
Respiratory
Respiratory side effects have included cough and dyspnea.
Cardiovascular
Cardiovascular side effects have included tachycardia.
TopMore resources:
Cefepime - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
A to Z Drug List
Drugs by Condition
Drug Side Effects
Natural Products
Community Forums
Interactions Checker
MedNotes
Support Groups
Drug Image Search
Phonetic Search
FDA Drug Alerts
New Drug Approvals
New Drug Applications
Clinical Trial Results
Medical Encyclopedia
News Feeds
Drugs by Classification
Patient Care Notes
Drug Imprint Codes
Medical Dictionary
Subscribe to our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.
